NDASUBCUTANEOUSSOLUTIONPriority Review
Approved
Jun 2025
Lifecycle
Launch
Competitive Pressure
0/100
Mechanism of Action
HIV-1 antiretroviral agent with long-acting properties [see ].
Loss of Exclusivity
LOE Date
Nov 25, 2040
179 months away
Patent Expiry
Nov 25, 2040
Exclusivity Expiry
Jun 18, 2028